Tag Archives: inappropriate for radiotherapy

Roche’s new medicine Erivedge received conditional EU approval for treatment of people with disfiguring and potentially life-threatening form of skin cancer

Posted on 19, July 2013 by

Erivedge is a new medicine that helps people with a disfiguring and potentially life-threatening form of skin cancer 19-7-2013 — /europawire.eu/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has granted conditional approval to Erivedge (vismodegib) … Read the full press release →

Posted in Business, European Union, Government, Healthcare, Pharma & Biotech, Switzerland

Tagged , , , , , ,